GuruFocus, November 5th ─ Jacobson Pharmaceutical (02633.HK) announced that a board meeting is scheduled to be held on Tuesday, November 18, 2025, to consider and approve the interim results for the six months ended September 30, 2025, of the Company and its subsidiaries for release. The board will also consider the distribution of an interim dividend, if any, and deal with other matters.
Jacobson Scientific Pharmaceuticals (02633.HK) plans to hold a board meeting on November 18 to approve the interim results.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Market Insights
Hot Stock Hot Stock
Top HK stocks viewed in the last 24 hours, capturing market sentiment and key capital flow insights. Top HK stocks viewed in the last 24 hours, capturing market sentiment and key capital flow insights.
View More